Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs

Autor:	Conti, A., Lasagni, C., Bigi, L., Pellacani, G.
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	therapies psoriasis biologic Letters to Editor Letter to Editor covid‐19 SARS‐CoV‐2
Zdroj:	Journal of the European Academy of Dermatology and Venereology
ISSN:	1468-3083 0926-9959
Popis:	Since December 2019, the pandemic coronavirus disease (2019‐nCoV; COVID‐19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of infection (1). However, few reports are available on the course of COVID‐19 infection in psoriatic patients treated with biological drugs (2). We describe a case series of four psoriatic patients treated with biologics who had a risk contact with COVID‐19.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::e349de2724899178c4267497e201012e http://europepmc.org/articles/PMC7267267 Zobrazit plný text záznamu Plný text